Cytarabine is a chemotherapy drug for treating acute leukemias such as acute myeloid leukemia. Doctors also use it for some lymphomas, including Hodgkin lymphoma. Healthcare professionals often ...

Annamycin, a chemotherapy drug with zero cardiotoxicity, is being tested for relapsed or refractory AML in the phase 3 MIRACLE trial. The trial, active in the U.S., Europe, and the Middle East, ...

Indium-111–Capromab Pendetide Radioimmunoscintigraphy and Prognosis for Durable Biochemical Response to Salvage Radiation Therapy in Men After Failed Prostatectomy Purpose: Troxacitabine has activity ...

A total of 24 patients (14 ALL, 3 AML, 3 DLBCL, 3 Burkitt and 1 T-cell lymphoblastic lymphoma) was prophylaxed with at least one dose of liposomal cytarabine over an 8-year period from 2004 to 2012.

Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. Age and serum lactate dehydrogenase level are independent prognostic factors in ...

Regarding consolidation therapy for younger patients with acute myeloid leukemia (AML), there was no survival benefit from taking high-dose vs intermediate-dose cytarabine. Numerous trials comparing ...

Cytarabine, aclarubicin, and granulocyte colony-stimulating factor (CAG) generates a positive effect for patients with acute myeloid leukemia (AML) by decreasing the number of immunosuppressive cell ...

An executive with Jazz Pharmaceuticals said the ability to extend survival time in patients with secondary AML, and potentially offer them improved odds for transplant is an advance over traditional ...

Granulocyte colony-stimulating factor (G-CSF) given concurrently with chemotherapy was recently shown to improve disease-free and overall survival in patients 18 to 60 years of age who had acute ...

Miracle Trial Preliminary Blinded CRc Rate of 40% in First 30 Patients Suggests Encouraging Early Results in Relapsed/Refractory AMLHOUSTON, ...

Results of the EORTC and GIMEMA (Gruppo Italiano Malattie Ematologiche dell' Adulto) AML-12 Trial appearing in the Journal of Clinical Oncology show that high-dose cytarabine in induction treatment ...